Table 4.
Overall infections | Infections of the airways | |||||
---|---|---|---|---|---|---|
RR | 95 % CI | p-Value | RR | 95 % CI | p-Value | |
Sustained systemic corticosteroidsa | 2.35 | 1.75–3.17 | <0.001 | 2.43 | 1.56–3.80 | <0.001 |
Active diseaseb | 1.13 | 0.77–1.66 | 0.534 | 1.51 | 0.97–2.35 | 0.069 |
Age at inclusion ≥65 yr vs. <65 yr | 0.99 | 0.66–1.48 | 0.947 | 0.87 | 0.51–1.48 | 0.604 |
Abbreviations: 95 % CI 95 % confidence interval, RR univariate relative risk
aPrednisone equivalent ≥10 mg/day at inclusion and at the end of follow-up vs. <10 mg/day
bPhysician Global Assessment score 2 and 3 (active and very active disease) vs. 0 and 1 (inactive or moderately active disease) at inclusion